ENGYSTOL cpr bte 250 pce

7680526510288 CH-52651 20.01.1.
ENGYSTOL cpr bte 250 pce
ENGYSTOL cpr bte 250 pce
ENGYSTOL cpr bte 250 pce
1 / 3
google

Details

Product number
5265101
CPT
-
Packaging group
250
Unit
Tablette(n)
Composition
vincetoxicum hirundinaria (HAB) D6 75 mg, vincetoxicum hirundinaria (HAB) D10 75 mg, vincetoxicum hirundinaria (HAB) D30 75 mg, sulfur (HAB) D4 (HAB 6) 37.5 mg, sulfur (HAB) D10 (HAB SV) 37.5 mg, magnesii stearas, lactosum monohydricum 300.0 mg, pro compresso 301.5 mg.

Articles (1)

Engystol, Tabletten
Tabletten
250
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/11/2024
Patient information leaflet
Français
12/11/2024
Patient information leaflet
Italien
12/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
75.0 MG Substance Wirkstoff (Principe actif)
(N/A)
75.0 MG Substance Wirkstoff (Principe actif)
(N/A)
75.0 MG Substance Wirkstoff (Principe actif)
(N/A)
37.5 MG Substance Wirkstoff (Principe actif)
(N/A)
37.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
300.0 MG Substance HBESI

Authorization holder

ebi-pharm ag

3038 Kirchlindach

Authorization information

Swissmedic authorization number
52651
Drug name
Engystol, Tabletten
Galenic form
TAB
Authorization status
Z
Dispensation category
D
First authorization
28/03/1994
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei grippalen Symptomen.

Packaging details

Description (FR)
ENGYSTOL cpr bte 250 pce
Description (DE)
ENGYSTOL Tabl Ds 250 Stk
Market launch
28/03/1994
Narcotic (BTM)
No

Other packaging sizes

ENGYSTOL cpr bte 50 pce
50 TABL
View